Nchi: Australia
Lugha: Kiingereza
Chanzo: APVMA (Australian Pesticides and Veterinary Medicines Authority)
ATIPAMEZOLE HYDROCHLORIDE
ZOETIS AUSTRALIA PTY LTD
atipamezole HCl(5mg/mL)
PARENTERAL LIQUID/SOLUTION/SUSPENSION
ATIPAMEZOLE HYDROCHLORIDE UNGROUPED Active 5.0 mg/ml
10mL
VM - Veterinary Medicine
CAT | DOG | BITCH | CASTRATE | CAT - QUEEN | CAT - TOM | KITTEN | PUPPY
ANTIDOTES
MEDETOMIDINE REVERSING AGENT&ANTAGONIST
Poison schedule: 4; Withholding period: WHP: N/A; Host/pest details: CAT: [MEDETOMIDINE REVERSING AGENT&ANTAGONIST]; DOG: [MEDETOMIDINE REVERSING AGENT&ANTAGONIST]; Poison schedule: 4; Withholding period: ; Host/pest details: CAT: [MEDETOMIDINE REVERSING AGENT&ANTAGONIST]; DOG: [MEDETOMIDINE REVERSING AGENT&ANTAGONIST]; For parenteral use in reversing and abolishing the effects of medetomidine hydrochloride in dogs and cats.
Registered
2023-07-01
Antipam Injection Relevant Label Particulars 02NOV12 [Copy in the header and footer will not appear on the final printed label} Vial label main panel PRESCRIPTION ANIMAL REMEDY KEEP OUT OF REACH OF CHILDREN FOR ANIMAL TREATMENT ONLY ANTI PAM INJECTION ACTIVE CONSTITUENT: ATIPAMEZOLE HYDROCHLORIDE 5 mglmL page 1/5 + RLP Approved FOR PARENTERAL USE IN REVERSING AND ABOLISHING THE EFFECTS OF MEDETOMIDINE HYDROCHLORIDE IN DOGS AND CATS 10 mL [Jurox logo] Vial label ancillary panel(s) READ THE ENCLOSED LEAFLET BEFORE USING THIS PRODUCT. DIRECTIONS FOR USE: REFER TO LEAFLET. Store below 30°C (Room Temperature). Do not freeze. Protect from light. APVMA Approval No: 65929/52317 Jurox Pty Limited 85 Gardiner Street, Rutherford, NSW 2320, Australia lnfoline 1800 023 312 B. EXP. JUROX PTY LIMITED Anti pam Injection Relevant Label Particulars 02NOV12 [Copy in the header and footer will not appear on the final printed label} Carton Front & Back Panel PRESCRIPTION ANIMAL REMEDY KEEP OUT OF REACH OF CHILDREN FOR ANIMAL TREATMENT ONLY ANTI PAM Injection ACTIVE CONSTITUENT: ATIPAMEZOLE HYDROCHLORIDE 5 mg/ml page 2/5 For parenteral use in reversing and abolishing the effects of medetomidine hydrochloride in dogs and cats [jurox logo] [10 ml] Carton: Side 1 READ THE ENCLOSED LEAFLET BEFORE USING THIS PRODUCT. DIRECTIONS FOR USE: Once broached, the product must be used within 3 months. Discard the unused portion. For parenteral use by intramuscular Injection. 5 times previous medetomidine hydrochloride* dose -400 2.5 times that of previous medetomidine hydrochloride* dose 25-375 Half of the volume medetomidine hydrochloride* dose *when formulated at 1 mg I mL medetomidine hydrochloride Jurox Pry Limited Antipam Injection Relevant Label Particulars 02NOV12 page 3/5 [Copy in the header and footer will not appear on the final printed label} Carton: Side 2 FIRST AID: If poisoning occurs, contact a doctor or Poisons Information Centre. Phone Australia 131126. Dispose of empty container by wrapping with paper and placing in the garbage. Soma hati kamili
ANTIPAM INJECTION Page 1 of 4 continued ISSUED: 4 MARCH 2014 SAFETY DATA SHEET SECTION 1: IDENTIFICATION OF CHEMICAL PRODUCT AND COMPANY PRODUCT NAME: ANTIPAM INJECTION PRODUCT CODE: 504280 (10 mL) RECOMMENDED USE: For parenteral use in reversing and abolishing the effects of medetomidine hydrochloride in dogs and cats. COMPANY IDENTIFICATION: Jurox Pty Limited ADDRESS: 85 Gardiner Street Rutherford NSW 2320 Australia CUSTOMER CENTRE: 1800 02 3312 NATIONAL POISONS INFORMATION CENTRE: 13 1126 (Australia-wide) EMERGENCY TELEPHONE NUMBER: 1800 02 3312 (9a.m. – 5p.m.) SECTION 2: HAZARDS IDENTIFICATION HAZARD STATUS: NOT HAZARDOUS ACCORDING TO GHS CRITERIA RISK PHRASES: None SECTION 3: COMPOSITION / INFORMATION ON INGREDIENTS INGREDIENT CAS NO. CONTENT Atipamezole hydrochloride 104075-48-1 0.5 % Other ingredients determined to be not hazardous To 100% SECTION 4: FIRST AID MEASURES FIRST AID MEASURES: Consult the National Poisons Centre on 131126 or a doctor immediately in every case of suspected chemical poisoning. Never give fluids or induce vomiting if a patient is unconscious or convulsing regardless of cause of injury. If medical advice/attention is needed, have product container or label at hand. INHALATION: Is unlikely to present an inhalation problem. If respiratory symptoms do occur, remove patient to fresh air. Lay patient down and keep warm and rested. INGESTION: Is unlikely to present an ingestion hazard. If swallowed, DO NOT induce vomiting. Rinse mouth. Keep subject warm and at rest. For advice, contact a doctor or the National Poisons Centre on 13 1126. SKIN: If skin contact occurs, wash affected area thoroughly with plenty of soap and water. If skin irritation or rash occurs, get medical advice. EYE: If eye contact occurs, rinse cautiously with water for at least 20 minutes. Continue rinsing. Ensure complete irrigation of the eye by keeping eyelids apart and away from eye and moving the eyelids by occasionally lifting the upper and lower lids. If eye irritation persists, get medical advice/attention. Soma hati kamili
WWW.JUROX.COM.AU Customer Service 1800 023 312 ® Registered Trademark of Jurox Pty Ltd TECHNICAL NOTES ACTIVE CONSTITUENTS Atipamezole hydrochloride 5 mg/mL ACTIONS Atipamezole is a selective alpha-2 adrenergic receptor antagonist. Atipamezole competitively occupies the alpha-2 receptor, preventing binding of alpha-2 drugs. INDICATIONS Atipamezole is capable of reversing and abolishing the effects of medetomidine hydrochloride in dogs and cats. DIRECTIONS FOR USE Once broached, the product must be used within 3 months. Discard the unused portion. For intramuscular injection. Antipam Injection is quickly absorbed and is generally administered 15 to 60 minutes after medetomidine hydrochloride. DOSE RATE For intramuscular injection in dogs and cats. DOSE (ΜG/KG) VOLUME DOGS (I/M INJECTION) 5 times that of previous medetomidine hydrochloride dose (50 - 400 µg/kg) The same volume as the medetomidine hydrochloride* dose CATS (I/M INJECTION) 2.5 times that of previous medetomidine hydrochloride dose (125 - 375 µg/kg) Half of the volume of the medetomidine hydrochloride* dose ANTIPAM Injection *when formulated at 1 mg/mL medetomidine hydrochloride WWW.JUROX.COM.AU Customer Service 1800 023 312 ® Registered Trademark of Jurox Pty Ltd TECHNICAL NOTES CONTRAINDICATIONS Not recommended in pregnant animals due to insufficient data. WARNINGS AND PRECAUTIONS Due to the potent pharmacological activity of atipamezole, avoid skin contact. Wipe off excessive spillage on skin of animals. SIDE EFFECTS In dogs, a transient hypotensive effect has been observed during the first 10 minutes post injection. Vomiting and panting after atipamezole injection have been reported but these effects appear to be rare. Transient over-alertness and tachycardia may be observed after possible overdose. FIRST AID If poisoning occurs, contact a doctor or Poisons Information Centre on 13 1126. DISPOSAL Dispose of empty container by wrapping with paper and placing in the garbage. PRESENTATION Clear solution 10 mL glass vial STORAGE Store below 30°C Soma hati kamili